The Business Research Company’s report on the Medical Foods For Orphan Diseases Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
What are the primary drivers fueling the growth of the medical foods for orphan diseases market in recent years?
The rising incidence of orphan diseases is expected to propel the growth of medical foods for the orphan diseases market going forward. Orphan disease, also known as a rare disease, is a medical condition that affects a relatively small number of individuals within a population. Medical foods are used to manage several orphan disorders to complete the specialized nutrition requirements of the patients. Hence, the rising incidence of orphan diseases contributes to the growth of the medical foods for orphan diseases market. For instance, in January 2023, according to the American Cancer Society, a US-based voluntary health organization, non-Hodgkin lymphoma, a rare disease, was one of the most common types of cancer in the United States and accounted for approximately 4% of cancer cases in 2023 where about 80,550 new diagnoses were estimated for 2023. Therefore, the increasing prevalence of orphan diseases is driving the medical foods for orphan diseases market.
Access Your Free Sample of the Global Medical Foods For Orphan Diseases Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=11940&type=smp
What is the projected market size of the medical foods for orphan diseases industry, and how is it expected to grow?
The medical foods for orphan diseases market size has grown strongly in recent years. It will grow from $1.33 billion in 2024 to $1.42 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to orphan drug designation, research & development advances, government funding & grants, regulatory frameworks, improved diagnosis
The medical foods for orphan diseases market size is expected to see strong growth in the next few years. It will grow to $1.82 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to telemedicine and remote monitoring, healthcare system integration, emerging technologies in food science, precision nutrition, increased patient demand. Major trends in the forecast period include long-term efficacy studies, disease-specific formulations, education and training programs, focus on gut microbiome, nutritional supplements innovation.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=11940&type=smp
Who are the key players driving competition in the medical foods for orphan diseases market?
Major companies operating in the medical foods for orphan diseases market include Nestle S.A., Abbott Laboratories Inc., Danone S.A., Ajinomoto Co. Inc., Meiji Holdings Co. Ltd., Fresenius Kabi AG, BioMarin Pharmaceutical Inc., Halyard Health, Alfasigma spA, Ultragenyx Pharmaceutical Inc., Immedica Group AB, Vitaflo International Ltd., Leadiant Biosciences Inc., Alcresta Therapeutics Inc., Cambrooke Therapeutics Inc., Primus Pharmaceuticals Inc., CANbridge Pharmaceuticals Inc., Cerecin Inc., AMNIOX Medical Inc., Targeted Medical Pharma Inc., Solace Nutrition LLC, Orphan Therapeutics LLC, Metagenics Inc., Farma Genetics Inc.
What key trends are expected to drive the medical foods for inborn errors of metabolism market during the forecast period?
Product innovations are a key trend gaining popularity in the medical foods for orphan diseases market. Major companies operating in the medical foods for orphan diseases market are introducing innovative products to sustain their position in the market. For instance, in October 2022, Relief Therapeutics, a Switzerland-based biopharmaceutical company, launched PKU GOLIKE. It is a next-generation medical food product engineered with the company’s patented Physiomimic Technology platform for the dietary management of phenylketonuria (PKU), a rare inherited disorder. PKU GOLIKE is the first prolonged-release amino acid product, characterized by a special coating that ensures physiological absorption of the amino acids while masking the unpleasant taste, odor, and aftertaste of the amino acids. It is a phenylalanine-free food intended for special medical purposes (FSMP) in the United States.
Which key geographies are driving the growth of the medical foods for orphan diseases market?
North America was the largest region in the medical foods for orphan diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical foods for orphan diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Order Your Report Now For Swift Delivery
What are the key segments driving growth in the medical foods for orphan diseases market?
The medical foods for orphan diseases market covered in this report is segmented –
1) By Product: Pills, Powder, Liquid, Other Products
2) By Route Of Administration: Oral, Enteral
3) By Applications: Phenylketonuria, Tyrosinemia, Eosinophilic esophagitis, Food Protein-Induced Enterocolitis Syndrome (FPIES), Maple Syrup Urine Disease (MSUD), Homocystinuria, Other Applications
4) By Sales Channel: Online Sales, Institutional Sales, Retail Sales
Subsegments:
1) By Pills, Tablets, Capsules
2) By Powder: Protein Powders, Nutritional Supplement Powders
3) By Liquid: Ready-To-Drink Formulas, Liquid Nutritional Supplements
4) By Other Products: Nutritional Bars, Fortified Foods, Ready-To-Use Therapeutic Foods
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11940
What defines the structure and scope of the medical foods for orphan diseases market?
Medical foods for orphan diseases refer to specialized nutritional products specifically formulated to meet the unique dietary needs of individuals affected by rare, genetic, or orphan diseases. These foods are used by patients suffering from rare orphan diseases.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
